Effect of severe acute pancreatitis on pharmacokinetics of Da-Cheng-Qi Decoction components.

World J Gastroenterol

Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

Published: December 2009

Aim: To investigate the effect of severe acute pancreatitis (SAP) on pharmacokinetics of Da-Cheng-Qi Decoction (DCQD) components in rats.

Methods: Rats were divided into SAP group and sham-operation group as a control group (n = 6). Rhein, chrysophanol, rheochrysidin, magnolol, hesperidin and naringin in DCQD were quantified in rat serum by high performance liquid chromatography tandem mass spectrometry for studying their pharmacokinetics.

Results: Early absorption of each DCQD component was tended to degrade in SAP group after treatment with DCQD by gavage. The C(max) (chrysophanol, P = 0.0059; rheochrysidin, P = 0.0288; magnolol, P = 0.0487; hesperidin, P = 0.0277; naringin, P = 0.0023) and AUC (rhein, P = 0.0186; chrysophanol, P = 0.0013; magnolol, P = 0.001; hesperidin, P = 0.0081; naringin, P = 0.0272) of DCQD component were obviously lower in SAP group than in control group. The T(1/2alpha) of chrysophanol and rheochrysidin (P = 0.0467 and 0.0005, respectively) and T(max) of chrysophanol and rheochrysidin (P = 0.0101 and 0.0037, respectively) lasted longer in SAP group than in control group.

Conclusion: SAP can significantly impact the absorption of DCQD components in rats and their pharmacokinetic parameters.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795188PMC
http://dx.doi.org/10.3748/wjg.15.5992DOI Listing

Publication Analysis

Top Keywords

sap group
16
group control
12
chrysophanol rheochrysidin
12
severe acute
8
acute pancreatitis
8
pharmacokinetics da-cheng-qi
8
da-cheng-qi decoction
8
dcqd components
8
control group
8
absorption dcqd
8

Similar Publications

In Europe, the prevalence of AF is expected to increase 2.5-fold over the next 50 years with a lifetime risk of 1 in 3-5 individuals after the age of 55 years and a 34% rise in AF-related strokes. The PREFATE project investigates evidence gaps in the early detection of atrial fibrillation in high-risk populations within primary care.

View Article and Find Full Text PDF

Role of Ciliary Neurotrophic Factor in Angiotensin II-Induced Hypertension.

Hypertension

January 2025

Department of Nephrology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany (S.A.P., I.Q., D. Arifaj, M.K., D. Argov, L.C.R., J.S.).

Background: Ciliary neurotrophic factor (CNTF), mainly known for its neuroprotective properties, belongs to the IL-6 (interleukin-6) cytokine family. In contrast to IL-6, the effects of CNTF on the vasculature have not been explored. Here, we examined the role of CNTF in AngII (angiotensin II)-induced hypertension.

View Article and Find Full Text PDF

Plants respond to attacks by insects by releasing herbivore-induced plant volatiles (HIPVs), which are known to influence the behavior of natural enemies, conspecific and heterospecific insects. However, little is known about how HIPVs induced by one insect species influence the behavior of an allospecific insect species, particularly if these insects belong to different feeding guilds. Here, using the interaction of two co-occurring insects with different feeding guilds - Bemisia tabaci (a sap sucking insect) and Tuta absoluta (a leaf mining insect) - on potato plants, we report that T.

View Article and Find Full Text PDF

Background And Aim: In the context of gastrointestinal diseases, the role of monoacylglycerol lipase (MAGL) is significant. Therefore, the objective of this study was to examine the protective effects of MAGL inhibition using JZL184 in rat models of severe acute pancreatitis (SAP) and to explore its mechanism.

Methods: In this study, a rat model of SAP was established, and the rats were divided into three groups for treatment: the Control group (CON), the SAP group (SAP), and the SAP group treated with JZL184 (JZL184).

View Article and Find Full Text PDF

Purpose: BMS-986299 is a first-in-class, NOD-, LRR-, and pyrin-domain containing-3 (NLRP3) inflammasome agonist enhancing adaptive immune and T-cell memory responses.

Materials And Methods: This was a phase-I (NCT03444753) study that assessed the safety and tolerability of intra-tumoral BMS-986299 monotherapy (part 1A) and in combination (part 1B) with nivolumab, and ipilimumab in advanced solid tumors. Reported here are single-center results.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!